This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, Universitë De Bordeaux, Université´ D'aix-Marseille. Active years: 2019.
Company Filing History:
1 out of 5,383 
1 out of 226 
1 out of 236 
Years Active: 2019
Title: Paul Bremond: Innovator in Cancer Treatment
Introduction
Paul Bremond is a notable inventor based in Marseille, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of alkoxyamines. His work has the potential to impact the lives of many individuals affected by cancer.
Latest Patents
Paul Bremond holds a patent for "Alkoxyamines for the treatment of cancers." This invention relates to alkoxyamines of general formula (I), and to compounds of general formula (IIa), (IIb), (IIc), (IId), (IIe), (IIf), or (IIg), as such and for the treatment of cancers. This patent highlights his commitment to advancing medical science and improving therapeutic options for cancer patients.
Career Highlights
Throughout his career, Paul Bremond has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université d'Aix-Marseille. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Paul has collaborated with notable colleagues, including Philippe Mellet and Sylvain Marque. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Paul Bremond is a dedicated inventor whose work in cancer treatment through alkoxyamines showcases his innovative spirit and commitment to improving healthcare. His contributions to research and collaboration with esteemed institutions and colleagues further emphasize his impact in the field.